nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—ABCC2—Dexamethasone—multiple sclerosis	0.0464	0.0762	CbGbCtD
Carbamazepine—ABCB1—Methylprednisolone—multiple sclerosis	0.04	0.0657	CbGbCtD
Carbamazepine—ABCC2—Methotrexate—multiple sclerosis	0.0373	0.0613	CbGbCtD
Carbamazepine—CYP3A4—Fingolimod—multiple sclerosis	0.0372	0.0611	CbGbCtD
Carbamazepine—CYP3A7—Dexamethasone—multiple sclerosis	0.031	0.0509	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.031	0.0509	CbGbCtD
Carbamazepine—CYP2C19—Prednisone—multiple sclerosis	0.03	0.0493	CbGbCtD
Carbamazepine—CYP2B6—Dexamethasone—multiple sclerosis	0.0295	0.0485	CbGbCtD
Carbamazepine—ABCB1—Mitoxantrone—multiple sclerosis	0.0292	0.0479	CbGbCtD
Carbamazepine—ABCB1—Betamethasone—multiple sclerosis	0.026	0.0427	CbGbCtD
Carbamazepine—ABCB1—Prednisolone—multiple sclerosis	0.0257	0.0421	CbGbCtD
Carbamazepine—ABCB1—Prednisone—multiple sclerosis	0.0242	0.0398	CbGbCtD
Carbamazepine—CYP3A4—Methylprednisolone—multiple sclerosis	0.024	0.0394	CbGbCtD
Carbamazepine—CYP3A5—Dexamethasone—multiple sclerosis	0.0233	0.0382	CbGbCtD
Carbamazepine—CYP2C8—Dexamethasone—multiple sclerosis	0.0224	0.0367	CbGbCtD
Carbamazepine—CYP2C19—Dexamethasone—multiple sclerosis	0.0188	0.0308	CbGbCtD
Carbamazepine—CYP3A4—Triamcinolone—multiple sclerosis	0.0182	0.0298	CbGbCtD
Carbamazepine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0175	0.0287	CbGbCtD
Carbamazepine—CYP2C9—Dexamethasone—multiple sclerosis	0.0156	0.0256	CbGbCtD
Carbamazepine—CYP3A4—Betamethasone—multiple sclerosis	0.0156	0.0256	CbGbCtD
Carbamazepine—CYP3A4—Prednisolone—multiple sclerosis	0.0154	0.0253	CbGbCtD
Carbamazepine—ABCB1—Dexamethasone—multiple sclerosis	0.0151	0.0248	CbGbCtD
Carbamazepine—CYP3A4—Prednisone—multiple sclerosis	0.0145	0.0238	CbGbCtD
Carbamazepine—ABCB1—Methotrexate—multiple sclerosis	0.0122	0.02	CbGbCtD
Carbamazepine—CYP3A4—Dexamethasone—multiple sclerosis	0.00907	0.0149	CbGbCtD
Carbamazepine—Ethopropazine—BCHE—multiple sclerosis	0.000439	0.419	CrCbGaD
Carbamazepine—Magnesium salicylate—ALB—multiple sclerosis	0.000307	0.293	CrCbGaD
Carbamazepine—Oxcarbazepine—ALB—multiple sclerosis	0.000181	0.173	CrCbGaD
Carbamazepine—Alopecia—Prednisone—multiple sclerosis	0.00016	0.000502	CcSEcCtD
Carbamazepine—Shock—Methylprednisolone—multiple sclerosis	0.00016	0.000502	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000159	0.000501	CcSEcCtD
Carbamazepine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000159	0.0005	CcSEcCtD
Carbamazepine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000159	0.0005	CcSEcCtD
Carbamazepine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000159	0.0005	CcSEcCtD
Carbamazepine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000159	0.000499	CcSEcCtD
Carbamazepine—Paraesthesia—Prednisolone—multiple sclerosis	0.000159	0.000499	CcSEcCtD
Carbamazepine—Tachycardia—Triamcinolone—multiple sclerosis	0.000159	0.000499	CcSEcCtD
Carbamazepine—Mental disorder—Prednisone—multiple sclerosis	0.000159	0.000498	CcSEcCtD
Carbamazepine—Nausea—Azathioprine—multiple sclerosis	0.000158	0.000498	CcSEcCtD
Carbamazepine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000158	0.000498	CcSEcCtD
Carbamazepine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000158	0.000495	CcSEcCtD
Carbamazepine—Erythema—Prednisone—multiple sclerosis	0.000158	0.000495	CcSEcCtD
Carbamazepine—Malnutrition—Prednisone—multiple sclerosis	0.000158	0.000495	CcSEcCtD
Carbamazepine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000157	0.000494	CcSEcCtD
Carbamazepine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000157	0.000494	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000157	0.000493	CcSEcCtD
Carbamazepine—Convulsion—Betamethasone—multiple sclerosis	0.000157	0.000492	CcSEcCtD
Carbamazepine—Convulsion—Dexamethasone—multiple sclerosis	0.000157	0.000492	CcSEcCtD
Carbamazepine—Hypertension—Dexamethasone—multiple sclerosis	0.000156	0.000491	CcSEcCtD
Carbamazepine—Hypertension—Betamethasone—multiple sclerosis	0.000156	0.000491	CcSEcCtD
Carbamazepine—Asthenia—Mitoxantrone—multiple sclerosis	0.000155	0.000486	CcSEcCtD
Carbamazepine—Myalgia—Dexamethasone—multiple sclerosis	0.000154	0.000484	CcSEcCtD
Carbamazepine—Myalgia—Betamethasone—multiple sclerosis	0.000154	0.000484	CcSEcCtD
Carbamazepine—Anxiety—Betamethasone—multiple sclerosis	0.000153	0.000482	CcSEcCtD
Carbamazepine—Anxiety—Dexamethasone—multiple sclerosis	0.000153	0.000482	CcSEcCtD
Carbamazepine—Hypotension—Methylprednisolone—multiple sclerosis	0.000152	0.000477	CcSEcCtD
Carbamazepine—Pain—Prednisolone—multiple sclerosis	0.000151	0.000475	CcSEcCtD
Carbamazepine—Hepatitis—Methotrexate—multiple sclerosis	0.000151	0.000475	CcSEcCtD
Carbamazepine—Pharyngitis—Methotrexate—multiple sclerosis	0.00015	0.000472	CcSEcCtD
Carbamazepine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000149	0.000469	CcSEcCtD
Carbamazepine—Vision blurred—Prednisone—multiple sclerosis	0.000148	0.000466	CcSEcCtD
Carbamazepine—Urethral disorder—Methotrexate—multiple sclerosis	0.000148	0.000466	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000148	0.000466	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000148	0.000465	CcSEcCtD
Carbamazepine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000148	0.000464	CcSEcCtD
Carbamazepine—Oedema—Betamethasone—multiple sclerosis	0.000148	0.000464	CcSEcCtD
Carbamazepine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000148	0.000464	CcSEcCtD
Carbamazepine—Oedema—Dexamethasone—multiple sclerosis	0.000148	0.000464	CcSEcCtD
Carbamazepine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000148	0.000464	CcSEcCtD
Carbamazepine—Insomnia—Triamcinolone—multiple sclerosis	0.000147	0.000462	CcSEcCtD
Carbamazepine—Insomnia—Methylprednisolone—multiple sclerosis	0.000147	0.000461	CcSEcCtD
Carbamazepine—Infection—Betamethasone—multiple sclerosis	0.000147	0.000461	CcSEcCtD
Carbamazepine—Infection—Dexamethasone—multiple sclerosis	0.000147	0.000461	CcSEcCtD
Carbamazepine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000146	0.000459	CcSEcCtD
Carbamazepine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000146	0.000458	CcSEcCtD
Carbamazepine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000146	0.000458	CcSEcCtD
Carbamazepine—Anaemia—Prednisone—multiple sclerosis	0.000146	0.000457	CcSEcCtD
Carbamazepine—Shock—Dexamethasone—multiple sclerosis	0.000145	0.000456	CcSEcCtD
Carbamazepine—Shock—Betamethasone—multiple sclerosis	0.000145	0.000456	CcSEcCtD
Carbamazepine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000145	0.000456	CcSEcCtD
Carbamazepine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000145	0.000455	CcSEcCtD
Carbamazepine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000145	0.000455	CcSEcCtD
Carbamazepine—Agitation—Prednisone—multiple sclerosis	0.000145	0.000455	CcSEcCtD
Carbamazepine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000145	0.000454	CcSEcCtD
Carbamazepine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000145	0.000454	CcSEcCtD
Carbamazepine—Tachycardia—Dexamethasone—multiple sclerosis	0.000144	0.000453	CcSEcCtD
Carbamazepine—Tachycardia—Betamethasone—multiple sclerosis	0.000144	0.000453	CcSEcCtD
Carbamazepine—Angioedema—Prednisone—multiple sclerosis	0.000144	0.000452	CcSEcCtD
Carbamazepine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000143	0.00045	CcSEcCtD
Carbamazepine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000143	0.000449	CcSEcCtD
Carbamazepine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000143	0.000449	CcSEcCtD
Carbamazepine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000143	0.000448	CcSEcCtD
Carbamazepine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000143	0.000448	CcSEcCtD
Carbamazepine—Vertigo—Prednisone—multiple sclerosis	0.000142	0.000445	CcSEcCtD
Carbamazepine—Eye disorder—Methotrexate—multiple sclerosis	0.000141	0.000444	CcSEcCtD
Carbamazepine—Syncope—Prednisone—multiple sclerosis	0.000141	0.000444	CcSEcCtD
Carbamazepine—Tinnitus—Methotrexate—multiple sclerosis	0.000141	0.000443	CcSEcCtD
Carbamazepine—Anorexia—Dexamethasone—multiple sclerosis	0.000141	0.000442	CcSEcCtD
Carbamazepine—Anorexia—Betamethasone—multiple sclerosis	0.000141	0.000442	CcSEcCtD
Carbamazepine—Urticaria—Prednisolone—multiple sclerosis	0.000141	0.000442	CcSEcCtD
Carbamazepine—Cardiac disorder—Methotrexate—multiple sclerosis	0.00014	0.000441	CcSEcCtD
Carbamazepine—Fatigue—Triamcinolone—multiple sclerosis	0.00014	0.000441	CcSEcCtD
Carbamazepine—Fatigue—Methylprednisolone—multiple sclerosis	0.00014	0.00044	CcSEcCtD
Carbamazepine—Pain—Triamcinolone—multiple sclerosis	0.000139	0.000437	CcSEcCtD
Carbamazepine—Loss of consciousness—Prednisone—multiple sclerosis	0.000138	0.000435	CcSEcCtD
Carbamazepine—Hypotension—Dexamethasone—multiple sclerosis	0.000138	0.000433	CcSEcCtD
Carbamazepine—Hypotension—Betamethasone—multiple sclerosis	0.000138	0.000433	CcSEcCtD
Carbamazepine—Angiopathy—Methotrexate—multiple sclerosis	0.000137	0.000431	CcSEcCtD
Carbamazepine—Vomiting—Mitoxantrone—multiple sclerosis	0.000137	0.000431	CcSEcCtD
Carbamazepine—Immune system disorder—Methotrexate—multiple sclerosis	0.000137	0.000429	CcSEcCtD
Carbamazepine—Convulsion—Prednisone—multiple sclerosis	0.000136	0.000429	CcSEcCtD
Carbamazepine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000136	0.000428	CcSEcCtD
Carbamazepine—Hypertension—Prednisone—multiple sclerosis	0.000136	0.000427	CcSEcCtD
Carbamazepine—Rash—Mitoxantrone—multiple sclerosis	0.000136	0.000427	CcSEcCtD
Carbamazepine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000136	0.000427	CcSEcCtD
Carbamazepine—Chills—Methotrexate—multiple sclerosis	0.000136	0.000426	CcSEcCtD
Carbamazepine—Headache—Mitoxantrone—multiple sclerosis	0.000135	0.000424	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000135	0.000423	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000135	0.000423	CcSEcCtD
Carbamazepine—Arthralgia—Prednisone—multiple sclerosis	0.000134	0.000421	CcSEcCtD
Carbamazepine—Myalgia—Prednisone—multiple sclerosis	0.000134	0.000421	CcSEcCtD
Carbamazepine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000134	0.000421	CcSEcCtD
Carbamazepine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000134	0.00042	CcSEcCtD
Carbamazepine—Anxiety—Prednisone—multiple sclerosis	0.000134	0.00042	CcSEcCtD
Carbamazepine—Alopecia—Methotrexate—multiple sclerosis	0.000134	0.00042	CcSEcCtD
Carbamazepine—Insomnia—Betamethasone—multiple sclerosis	0.000134	0.00042	CcSEcCtD
Carbamazepine—Insomnia—Dexamethasone—multiple sclerosis	0.000134	0.00042	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000133	0.000418	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000133	0.000417	CcSEcCtD
Carbamazepine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000133	0.000417	CcSEcCtD
Carbamazepine—Paraesthesia—Betamethasone—multiple sclerosis	0.000133	0.000417	CcSEcCtD
Carbamazepine—Mental disorder—Methotrexate—multiple sclerosis	0.000132	0.000416	CcSEcCtD
Carbamazepine—Malnutrition—Methotrexate—multiple sclerosis	0.000132	0.000414	CcSEcCtD
Carbamazepine—Erythema—Methotrexate—multiple sclerosis	0.000132	0.000414	CcSEcCtD
Carbamazepine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00013	0.00041	CcSEcCtD
Carbamazepine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00013	0.000408	CcSEcCtD
Carbamazepine—Dyspepsia—Betamethasone—multiple sclerosis	0.00013	0.000408	CcSEcCtD
Carbamazepine—Urticaria—Triamcinolone—multiple sclerosis	0.000129	0.000406	CcSEcCtD
Carbamazepine—Urticaria—Methylprednisolone—multiple sclerosis	0.000129	0.000405	CcSEcCtD
Carbamazepine—Dysgeusia—Methotrexate—multiple sclerosis	0.000129	0.000405	CcSEcCtD
Carbamazepine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000129	0.000404	CcSEcCtD
Carbamazepine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000129	0.000404	CcSEcCtD
Carbamazepine—Oedema—Prednisone—multiple sclerosis	0.000129	0.000404	CcSEcCtD
Carbamazepine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000128	0.000403	CcSEcCtD
Carbamazepine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000128	0.000403	CcSEcCtD
Carbamazepine—Decreased appetite—Betamethasone—multiple sclerosis	0.000128	0.000403	CcSEcCtD
Carbamazepine—Nausea—Mitoxantrone—multiple sclerosis	0.000128	0.000402	CcSEcCtD
Carbamazepine—Infection—Prednisone—multiple sclerosis	0.000128	0.000401	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000127	0.0004	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000127	0.0004	CcSEcCtD
Carbamazepine—Back pain—Methotrexate—multiple sclerosis	0.000127	0.0004	CcSEcCtD
Carbamazepine—Fatigue—Betamethasone—multiple sclerosis	0.000127	0.0004	CcSEcCtD
Carbamazepine—Fatigue—Dexamethasone—multiple sclerosis	0.000127	0.0004	CcSEcCtD
Carbamazepine—Shock—Prednisone—multiple sclerosis	0.000126	0.000397	CcSEcCtD
Carbamazepine—Pain—Dexamethasone—multiple sclerosis	0.000126	0.000397	CcSEcCtD
Carbamazepine—Pain—Betamethasone—multiple sclerosis	0.000126	0.000397	CcSEcCtD
Carbamazepine—Nervous system disorder—Prednisone—multiple sclerosis	0.000126	0.000396	CcSEcCtD
Carbamazepine—Tachycardia—Prednisone—multiple sclerosis	0.000125	0.000394	CcSEcCtD
Carbamazepine—Skin disorder—Prednisone—multiple sclerosis	0.000125	0.000392	CcSEcCtD
Carbamazepine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000124	0.000391	CcSEcCtD
Carbamazepine—Vision blurred—Methotrexate—multiple sclerosis	0.000124	0.00039	CcSEcCtD
Carbamazepine—Anorexia—Prednisone—multiple sclerosis	0.000123	0.000385	CcSEcCtD
Carbamazepine—Anaemia—Methotrexate—multiple sclerosis	0.000122	0.000382	CcSEcCtD
Carbamazepine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000122	0.000382	CcSEcCtD
Carbamazepine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000122	0.000382	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000121	0.000379	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000121	0.000379	CcSEcCtD
Carbamazepine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00012	0.000377	CcSEcCtD
Carbamazepine—Phenytoin—ALB—multiple sclerosis	0.00012	0.114	CrCbGaD
Carbamazepine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00012	0.000376	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—CCR1—multiple sclerosis	0.000119	0.00166	CbGpPWpGaD
Carbamazepine—Vertigo—Methotrexate—multiple sclerosis	0.000118	0.000372	CcSEcCtD
Carbamazepine—Leukopenia—Methotrexate—multiple sclerosis	0.000118	0.00037	CcSEcCtD
Carbamazepine—Urticaria—Betamethasone—multiple sclerosis	0.000117	0.000369	CcSEcCtD
Carbamazepine—Urticaria—Dexamethasone—multiple sclerosis	0.000117	0.000369	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000117	0.000368	CcSEcCtD
Carbamazepine—Dizziness—Prednisolone—multiple sclerosis	0.000117	0.000368	CcSEcCtD
Carbamazepine—Asthenia—Triamcinolone—multiple sclerosis	0.000117	0.000367	CcSEcCtD
Carbamazepine—Abdominal pain—Betamethasone—multiple sclerosis	0.000117	0.000367	CcSEcCtD
Carbamazepine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000117	0.000367	CcSEcCtD
Carbamazepine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000117	0.000367	CcSEcCtD
Carbamazepine—Body temperature increased—Betamethasone—multiple sclerosis	0.000117	0.000367	CcSEcCtD
Carbamazepine—Asthenia—Methylprednisolone—multiple sclerosis	0.000116	0.000366	CcSEcCtD
Carbamazepine—Insomnia—Prednisone—multiple sclerosis	0.000116	0.000365	CcSEcCtD
Carbamazepine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000116	0.00161	CbGpPWpGaD
Carbamazepine—Paraesthesia—Prednisone—multiple sclerosis	0.000115	0.000363	CcSEcCtD
Carbamazepine—Pruritus—Triamcinolone—multiple sclerosis	0.000115	0.000362	CcSEcCtD
Carbamazepine—Pruritus—Methylprednisolone—multiple sclerosis	0.000115	0.000361	CcSEcCtD
Carbamazepine—Convulsion—Methotrexate—multiple sclerosis	0.000114	0.000358	CcSEcCtD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000114	0.00159	CbGpPWpGaD
Carbamazepine—Dyspepsia—Prednisone—multiple sclerosis	0.000113	0.000356	CcSEcCtD
Carbamazepine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000113	0.00158	CbGpPWpGaD
Carbamazepine—Myalgia—Methotrexate—multiple sclerosis	0.000112	0.000352	CcSEcCtD
Carbamazepine—Chest pain—Methotrexate—multiple sclerosis	0.000112	0.000352	CcSEcCtD
Carbamazepine—Arthralgia—Methotrexate—multiple sclerosis	0.000112	0.000352	CcSEcCtD
Carbamazepine—Decreased appetite—Prednisone—multiple sclerosis	0.000112	0.000351	CcSEcCtD
Carbamazepine—Rash—Prednisolone—multiple sclerosis	0.000112	0.000351	CcSEcCtD
Carbamazepine—Dermatitis—Prednisolone—multiple sclerosis	0.000111	0.00035	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000111	0.00035	CcSEcCtD
Carbamazepine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000111	0.000349	CcSEcCtD
Carbamazepine—Fatigue—Prednisone—multiple sclerosis	0.000111	0.000348	CcSEcCtD
Carbamazepine—Headache—Prednisolone—multiple sclerosis	0.000111	0.000348	CcSEcCtD
Carbamazepine—Constipation—Prednisone—multiple sclerosis	0.00011	0.000345	CcSEcCtD
Carbamazepine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.00011	0.00153	CbGpPWpGaD
Carbamazepine—Confusional state—Methotrexate—multiple sclerosis	0.000108	0.00034	CcSEcCtD
Carbamazepine—Dizziness—Triamcinolone—multiple sclerosis	0.000108	0.000338	CcSEcCtD
Carbamazepine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000107	0.000338	CcSEcCtD
Carbamazepine—Dizziness—Methylprednisolone—multiple sclerosis	0.000107	0.000337	CcSEcCtD
Carbamazepine—Infection—Methotrexate—multiple sclerosis	0.000107	0.000335	CcSEcCtD
Carbamazepine—UGT2B7—Metabolism—SRM—multiple sclerosis	0.000106	0.00148	CbGpPWpGaD
Carbamazepine—Feeling abnormal—Prednisone—multiple sclerosis	0.000106	0.000333	CcSEcCtD
Carbamazepine—Asthenia—Betamethasone—multiple sclerosis	0.000106	0.000333	CcSEcCtD
Carbamazepine—Asthenia—Dexamethasone—multiple sclerosis	0.000106	0.000333	CcSEcCtD
Carbamazepine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000105	0.000331	CcSEcCtD
Carbamazepine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000105	0.000331	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000105	0.00033	CcSEcCtD
Carbamazepine—Nausea—Prednisolone—multiple sclerosis	0.000105	0.00033	CcSEcCtD
Carbamazepine—Pruritus—Betamethasone—multiple sclerosis	0.000104	0.000328	CcSEcCtD
Carbamazepine—Pruritus—Dexamethasone—multiple sclerosis	0.000104	0.000328	CcSEcCtD
Carbamazepine—Skin disorder—Methotrexate—multiple sclerosis	0.000104	0.000328	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000104	0.000326	CcSEcCtD
Carbamazepine—Vomiting—Triamcinolone—multiple sclerosis	0.000103	0.000325	CcSEcCtD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000103	0.00144	CbGpPWpGaD
Carbamazepine—Vomiting—Methylprednisolone—multiple sclerosis	0.000103	0.000324	CcSEcCtD
Carbamazepine—Rash—Triamcinolone—multiple sclerosis	0.000103	0.000322	CcSEcCtD
Carbamazepine—Dermatitis—Triamcinolone—multiple sclerosis	0.000102	0.000322	CcSEcCtD
Carbamazepine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000102	0.00143	CbGpPWpGaD
Carbamazepine—Anorexia—Methotrexate—multiple sclerosis	0.000102	0.000322	CcSEcCtD
Carbamazepine—Rash—Methylprednisolone—multiple sclerosis	0.000102	0.000322	CcSEcCtD
Carbamazepine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000102	0.000321	CcSEcCtD
Carbamazepine—Urticaria—Prednisone—multiple sclerosis	0.000102	0.000321	CcSEcCtD
Carbamazepine—Headache—Triamcinolone—multiple sclerosis	0.000102	0.00032	CcSEcCtD
Carbamazepine—Headache—Methylprednisolone—multiple sclerosis	0.000102	0.00032	CcSEcCtD
Carbamazepine—Body temperature increased—Prednisone—multiple sclerosis	0.000102	0.000319	CcSEcCtD
Carbamazepine—Abdominal pain—Prednisone—multiple sclerosis	0.000102	0.000319	CcSEcCtD
Carbamazepine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000101	0.000317	CcSEcCtD
Carbamazepine—Diarrhoea—Betamethasone—multiple sclerosis	0.000101	0.000317	CcSEcCtD
Carbamazepine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000101	0.0014	CbGpPWpGaD
Carbamazepine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000101	0.0014	CbGpPWpGaD
Carbamazepine—Hypotension—Methotrexate—multiple sclerosis	0.0001	0.000315	CcSEcCtD
Carbamazepine—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	0.0001	0.0014	CbGpPWpGaD
Carbamazepine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.91e-05	0.00138	CbGpPWpGaD
Carbamazepine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.91e-05	0.00138	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	9.87e-05	0.00138	CbGpPWpGaD
Carbamazepine—UGT2B7—Biological oxidations—POMC—multiple sclerosis	9.84e-05	0.00137	CbGpPWpGaD
Carbamazepine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.79e-05	0.000308	CcSEcCtD
Carbamazepine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.78e-05	0.00137	CbGpPWpGaD
Carbamazepine—Dizziness—Dexamethasone—multiple sclerosis	9.76e-05	0.000307	CcSEcCtD
Carbamazepine—Dizziness—Betamethasone—multiple sclerosis	9.76e-05	0.000307	CcSEcCtD
Carbamazepine—Insomnia—Methotrexate—multiple sclerosis	9.72e-05	0.000305	CcSEcCtD
Carbamazepine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	9.68e-05	0.00135	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	9.68e-05	0.00135	CbGpPWpGaD
Carbamazepine—Nausea—Triamcinolone—multiple sclerosis	9.66e-05	0.000304	CcSEcCtD
Carbamazepine—Paraesthesia—Methotrexate—multiple sclerosis	9.65e-05	0.000303	CcSEcCtD
Carbamazepine—Nausea—Methylprednisolone—multiple sclerosis	9.64e-05	0.000303	CcSEcCtD
Carbamazepine—Dyspnoea—Methotrexate—multiple sclerosis	9.58e-05	0.000301	CcSEcCtD
Carbamazepine—Somnolence—Methotrexate—multiple sclerosis	9.55e-05	0.0003	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—TYK2—multiple sclerosis	9.54e-05	0.00133	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	9.48e-05	0.00132	CbGpPWpGaD
Carbamazepine—Hypersensitivity—Prednisone—multiple sclerosis	9.47e-05	0.000298	CcSEcCtD
Carbamazepine—Dyspepsia—Methotrexate—multiple sclerosis	9.46e-05	0.000297	CcSEcCtD
Carbamazepine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	9.41e-05	0.00131	CbGpPWpGaD
Carbamazepine—Vomiting—Dexamethasone—multiple sclerosis	9.39e-05	0.000295	CcSEcCtD
Carbamazepine—Vomiting—Betamethasone—multiple sclerosis	9.39e-05	0.000295	CcSEcCtD
Carbamazepine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.37e-05	0.00131	CbGpPWpGaD
Carbamazepine—Decreased appetite—Methotrexate—multiple sclerosis	9.34e-05	0.000293	CcSEcCtD
Carbamazepine—Rash—Dexamethasone—multiple sclerosis	9.31e-05	0.000292	CcSEcCtD
Carbamazepine—Rash—Betamethasone—multiple sclerosis	9.31e-05	0.000292	CcSEcCtD
Carbamazepine—Dermatitis—Betamethasone—multiple sclerosis	9.3e-05	0.000292	CcSEcCtD
Carbamazepine—Dermatitis—Dexamethasone—multiple sclerosis	9.3e-05	0.000292	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.28e-05	0.000291	CcSEcCtD
Carbamazepine—Fatigue—Methotrexate—multiple sclerosis	9.26e-05	0.000291	CcSEcCtD
Carbamazepine—Headache—Betamethasone—multiple sclerosis	9.25e-05	0.000291	CcSEcCtD
Carbamazepine—Headache—Dexamethasone—multiple sclerosis	9.25e-05	0.000291	CcSEcCtD
Carbamazepine—Asthenia—Prednisone—multiple sclerosis	9.22e-05	0.00029	CcSEcCtD
Carbamazepine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	9.2e-05	0.00128	CbGpPWpGaD
Carbamazepine—Pain—Methotrexate—multiple sclerosis	9.19e-05	0.000289	CcSEcCtD
Carbamazepine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.16e-05	0.00128	CbGpPWpGaD
Carbamazepine—Pruritus—Prednisone—multiple sclerosis	9.1e-05	0.000286	CcSEcCtD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	8.91e-05	0.00124	CbGpPWpGaD
Carbamazepine—Feeling abnormal—Methotrexate—multiple sclerosis	8.85e-05	0.000278	CcSEcCtD
Carbamazepine—Diarrhoea—Prednisone—multiple sclerosis	8.8e-05	0.000276	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.79e-05	0.000276	CcSEcCtD
Carbamazepine—SCN4A—Axon guidance—TYK2—multiple sclerosis	8.77e-05	0.00122	CbGpPWpGaD
Carbamazepine—Nausea—Dexamethasone—multiple sclerosis	8.77e-05	0.000276	CcSEcCtD
Carbamazepine—Nausea—Betamethasone—multiple sclerosis	8.77e-05	0.000276	CcSEcCtD
Carbamazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.73e-05	0.00122	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	8.67e-05	0.00121	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	8.62e-05	0.0012	CbGpPWpGaD
Carbamazepine—Urticaria—Methotrexate—multiple sclerosis	8.54e-05	0.000268	CcSEcCtD
Carbamazepine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	8.53e-05	0.00119	CbGpPWpGaD
Carbamazepine—Dizziness—Prednisone—multiple sclerosis	8.5e-05	0.000267	CcSEcCtD
Carbamazepine—Abdominal pain—Methotrexate—multiple sclerosis	8.49e-05	0.000267	CcSEcCtD
Carbamazepine—Body temperature increased—Methotrexate—multiple sclerosis	8.49e-05	0.000267	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—CCL3—multiple sclerosis	8.49e-05	0.00119	CbGpPWpGaD
Carbamazepine—Vomiting—Prednisone—multiple sclerosis	8.17e-05	0.000257	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—PTGER4—multiple sclerosis	8.17e-05	0.00114	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.16e-05	0.00114	CbGpPWpGaD
Carbamazepine—Rash—Prednisone—multiple sclerosis	8.11e-05	0.000255	CcSEcCtD
Carbamazepine—Dermatitis—Prednisone—multiple sclerosis	8.1e-05	0.000254	CcSEcCtD
Carbamazepine—Headache—Prednisone—multiple sclerosis	8.05e-05	0.000253	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—PGR—multiple sclerosis	8.05e-05	0.00112	CbGpPWpGaD
Carbamazepine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.96e-05	0.00111	CbGpPWpGaD
Carbamazepine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.93e-05	0.00111	CbGpPWpGaD
Carbamazepine—Hypersensitivity—Methotrexate—multiple sclerosis	7.92e-05	0.000249	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—CXCR3—multiple sclerosis	7.89e-05	0.0011	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CD28—multiple sclerosis	7.82e-05	0.00109	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	7.79e-05	0.00109	CbGpPWpGaD
Carbamazepine—Asthenia—Methotrexate—multiple sclerosis	7.71e-05	0.000242	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—CCR2—multiple sclerosis	7.68e-05	0.00107	CbGpPWpGaD
Carbamazepine—Nausea—Prednisone—multiple sclerosis	7.64e-05	0.00024	CcSEcCtD
Carbamazepine—Pruritus—Methotrexate—multiple sclerosis	7.6e-05	0.000239	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—MMP9—multiple sclerosis	7.52e-05	0.00105	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CYP24A1—multiple sclerosis	7.48e-05	0.00104	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CYP27B1—multiple sclerosis	7.48e-05	0.00104	CbGpPWpGaD
Carbamazepine—Diarrhoea—Methotrexate—multiple sclerosis	7.35e-05	0.000231	CcSEcCtD
Carbamazepine—CYP3A7—Metabolism—SRM—multiple sclerosis	7.26e-05	0.00101	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.22e-05	0.00101	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	7.2e-05	0.001	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.19e-05	0.001	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.19e-05	0.001	CbGpPWpGaD
Carbamazepine—Dizziness—Methotrexate—multiple sclerosis	7.11e-05	0.000223	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—CNR1—multiple sclerosis	7.08e-05	0.000989	CbGpPWpGaD
Carbamazepine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.08e-05	0.000988	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	7e-05	0.000977	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—MMP9—multiple sclerosis	6.91e-05	0.000964	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GPC5—multiple sclerosis	6.85e-05	0.000956	CbGpPWpGaD
Carbamazepine—Vomiting—Methotrexate—multiple sclerosis	6.83e-05	0.000215	CcSEcCtD
Carbamazepine—SCN9A—Developmental Biology—TYK2—multiple sclerosis	6.81e-05	0.000951	CbGpPWpGaD
Carbamazepine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.8e-05	0.00095	CbGpPWpGaD
Carbamazepine—Rash—Methotrexate—multiple sclerosis	6.77e-05	0.000213	CcSEcCtD
Carbamazepine—Dermatitis—Methotrexate—multiple sclerosis	6.77e-05	0.000213	CcSEcCtD
Carbamazepine—Headache—Methotrexate—multiple sclerosis	6.73e-05	0.000211	CcSEcCtD
Carbamazepine—CYP3A7—Biological oxidations—POMC—multiple sclerosis	6.73e-05	0.000939	CbGpPWpGaD
Carbamazepine—UGT2B7—NRF2 pathway—TGFB1—multiple sclerosis	6.47e-05	0.000904	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	6.47e-05	0.000903	CbGpPWpGaD
Carbamazepine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.45e-05	0.000901	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.42e-05	0.000896	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.42e-05	0.000896	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.41e-05	0.000895	CbGpPWpGaD
Carbamazepine—Nausea—Methotrexate—multiple sclerosis	6.38e-05	0.000201	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—CXCL10—multiple sclerosis	6.38e-05	0.000891	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—TYK2—multiple sclerosis	6.26e-05	0.000874	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.24e-05	0.000872	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.23e-05	0.00087	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.22e-05	0.000869	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—MAPK1—multiple sclerosis	6.07e-05	0.000848	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—TYK2—multiple sclerosis	5.94e-05	0.00083	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.85e-05	0.000817	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.85e-05	0.000817	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	5.79e-05	0.000809	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	5.69e-05	0.000794	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—RRM1—multiple sclerosis	5.67e-05	0.000792	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—MAPK1—multiple sclerosis	5.58e-05	0.000779	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CD86—multiple sclerosis	5.58e-05	0.000779	CbGpPWpGaD
Carbamazepine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.52e-05	0.00077	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CCL5—multiple sclerosis	5.49e-05	0.000767	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SRM—multiple sclerosis	5.37e-05	0.00075	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MMP9—multiple sclerosis	5.36e-05	0.000749	CbGpPWpGaD
Carbamazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.25e-05	0.000733	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SRM—multiple sclerosis	5.25e-05	0.000733	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.22e-05	0.000728	CbGpPWpGaD
Carbamazepine—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	5.13e-05	0.000716	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	5.11e-05	0.000714	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	5.11e-05	0.000714	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SPP1—multiple sclerosis	5.09e-05	0.00071	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.07e-05	0.000709	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.06e-05	0.000706	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5e-05	0.000698	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5e-05	0.000698	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5e-05	0.000698	CbGpPWpGaD
Carbamazepine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	4.98e-05	0.000695	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CCR5—multiple sclerosis	4.95e-05	0.000691	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MMP9—multiple sclerosis	4.93e-05	0.000688	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL2RA—multiple sclerosis	4.88e-05	0.000681	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.86e-05	0.000679	CbGpPWpGaD
Carbamazepine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	4.86e-05	0.000679	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.86e-05	0.000678	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.85e-05	0.000678	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—STAT3—multiple sclerosis	4.77e-05	0.000666	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.76e-05	0.000664	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—MMP9—multiple sclerosis	4.68e-05	0.000654	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GPC5—multiple sclerosis	4.68e-05	0.000653	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—IL6—multiple sclerosis	4.67e-05	0.000652	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SRM—multiple sclerosis	4.55e-05	0.000635	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.53e-05	0.000633	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.53e-05	0.000633	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—APOE—multiple sclerosis	4.5e-05	0.000628	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—TGFB1—multiple sclerosis	4.42e-05	0.000617	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—STAT3—multiple sclerosis	4.38e-05	0.000612	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MAPK1—multiple sclerosis	4.33e-05	0.000605	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—IL6—multiple sclerosis	4.29e-05	0.000599	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.28e-05	0.000598	CbGpPWpGaD
Carbamazepine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.26e-05	0.000594	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—TYK2—multiple sclerosis	4.24e-05	0.000592	CbGpPWpGaD
Carbamazepine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.21e-05	0.000588	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—TNF—multiple sclerosis	4.13e-05	0.000576	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CD80—multiple sclerosis	4.07e-05	0.000568	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—TGFB1—multiple sclerosis	4.06e-05	0.000567	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SRM—multiple sclerosis	4.06e-05	0.000566	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MAPK1—multiple sclerosis	3.98e-05	0.000556	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SRM—multiple sclerosis	3.96e-05	0.000553	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.94e-05	0.000551	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—RRM1—multiple sclerosis	3.88e-05	0.000541	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—POMC—multiple sclerosis	3.87e-05	0.00054	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.84e-05	0.000536	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—TNF—multiple sclerosis	3.79e-05	0.00053	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—MAPK1—multiple sclerosis	3.78e-05	0.000528	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CCL2—multiple sclerosis	3.78e-05	0.000528	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	3.78e-05	0.000528	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	3.78e-05	0.000528	CbGpPWpGaD
Carbamazepine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.76e-05	0.000525	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SRM—multiple sclerosis	3.7e-05	0.000517	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.7e-05	0.000516	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.7e-05	0.000516	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.68e-05	0.000514	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.46e-05	0.000483	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TYK2—multiple sclerosis	3.44e-05	0.00048	CbGpPWpGaD
Carbamazepine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.43e-05	0.000479	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.39e-05	0.000474	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.38e-05	0.000472	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MMP9—multiple sclerosis	3.34e-05	0.000466	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—IL6—multiple sclerosis	3.33e-05	0.000465	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—BCHE—multiple sclerosis	3.26e-05	0.000455	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.2e-05	0.000447	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.2e-05	0.000447	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SRM—multiple sclerosis	3.16e-05	0.000441	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.13e-05	0.000437	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—IL6—multiple sclerosis	3.06e-05	0.000427	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—STAT3—multiple sclerosis	2.97e-05	0.000415	CbGpPWpGaD
Carbamazepine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.93e-05	0.000409	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.93e-05	0.000409	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—IL6—multiple sclerosis	2.91e-05	0.000406	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.87e-05	0.0004	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.86e-05	0.000399	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.86e-05	0.000399	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL2—multiple sclerosis	2.86e-05	0.000399	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.8e-05	0.000391	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.79e-05	0.00039	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.79e-05	0.00039	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.79e-05	0.00039	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	2.75e-05	0.000384	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MMP9—multiple sclerosis	2.71e-05	0.000378	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	2.7e-05	0.000377	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.61e-05	0.000365	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.61e-05	0.000364	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.61e-05	0.000364	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.6e-05	0.000363	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—TNF—multiple sclerosis	2.57e-05	0.000359	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GPC5—multiple sclerosis	2.55e-05	0.000356	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.55e-05	0.000356	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.44e-05	0.000341	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.43e-05	0.000339	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—STAT3—multiple sclerosis	2.41e-05	0.000336	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.38e-05	0.000333	CbGpPWpGaD
Carbamazepine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.26e-05	0.000316	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MYC—multiple sclerosis	2.23e-05	0.000312	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TGFB1—multiple sclerosis	2.23e-05	0.000311	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.23e-05	0.000311	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.23e-05	0.000311	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.23e-05	0.000311	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MAPK1—multiple sclerosis	2.19e-05	0.000305	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.18e-05	0.000304	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.17e-05	0.000302	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—RRM1—multiple sclerosis	2.11e-05	0.000295	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—IL6—multiple sclerosis	2.07e-05	0.00029	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.04e-05	0.000284	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.98e-05	0.000276	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—APOE—multiple sclerosis	1.96e-05	0.000274	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.95e-05	0.000272	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.95e-05	0.000272	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.91e-05	0.000266	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.88e-05	0.000263	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.82e-05	0.000254	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.72e-05	0.00024	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.72e-05	0.00024	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.69e-05	0.000236	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—POMC—multiple sclerosis	1.68e-05	0.000235	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.68e-05	0.000235	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL6—multiple sclerosis	1.68e-05	0.000235	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.65e-05	0.00023	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.62e-05	0.000226	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.000225	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.57e-05	0.00022	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ALB—multiple sclerosis	1.53e-05	0.000214	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.53e-05	0.000214	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.47e-05	0.000206	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.44e-05	0.000202	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.39e-05	0.000195	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—APOE—multiple sclerosis	1.34e-05	0.000187	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.32e-05	0.000184	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.32e-05	0.000184	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.31e-05	0.000183	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.3e-05	0.000182	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.24e-05	0.000174	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.22e-05	0.000171	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.21e-05	0.00017	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.2e-05	0.000168	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—POMC—multiple sclerosis	1.15e-05	0.000161	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000158	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	0.000157	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ALB—multiple sclerosis	1.05e-05	0.000146	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.03e-05	0.000143	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—APOE—multiple sclerosis	9.91e-06	0.000138	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.69e-06	0.000135	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—APOE—multiple sclerosis	9.68e-06	0.000135	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—POMC—multiple sclerosis	8.51e-06	0.000119	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—APOE—multiple sclerosis	8.39e-06	0.000117	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—POMC—multiple sclerosis	8.32e-06	0.000116	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ALB—multiple sclerosis	7.76e-06	0.000108	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ALB—multiple sclerosis	7.58e-06	0.000106	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—APOE—multiple sclerosis	7.48e-06	0.000105	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.48e-06	0.000104	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—APOE—multiple sclerosis	7.31e-06	0.000102	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—POMC—multiple sclerosis	7.2e-06	0.000101	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—APOE—multiple sclerosis	6.82e-06	9.53e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ALB—multiple sclerosis	6.57e-06	9.17e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—POMC—multiple sclerosis	6.43e-06	8.98e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—POMC—multiple sclerosis	6.28e-06	8.76e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—POMC—multiple sclerosis	5.86e-06	8.19e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALB—multiple sclerosis	5.86e-06	8.19e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—APOE—multiple sclerosis	5.83e-06	8.14e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALB—multiple sclerosis	5.72e-06	7.99e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALB—multiple sclerosis	5.35e-06	7.46e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—POMC—multiple sclerosis	5.01e-06	7e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALB—multiple sclerosis	4.57e-06	6.38e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.5e-06	6.28e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.87e-06	5.4e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.53e-06	4.92e-05	CbGpPWpGaD
